Edwards Lifesciences Corporation provided earnings guidance for the full year 2023. For the year, the company expects its sales to grow in the 9% to 12% range.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.37 USD | -1.04% |
|
+1.62% | +21.14% |
06-20 | Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing | MT |
06-17 | Edwards Lifesciences Corporation Announces Executive Changes | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.14% | 55.66B | |
+4.18% | 211B | |
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B | |
+11.28% | 28.12B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Edwards Lifesciences Corporation Provides Earnings Guidance for the Full Year 2023